Dried Blood Spot COVID-19 Vaccination Response (Enrolling by Invitation Only)


About this study

The purpose of this study is to evaluate the accuracy of the Luminex anti-SARS-CoV-2 IgG assay performed on self-collected dried blood spot samples collected pre- and post- SARS-CoV-2 vaccination.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults ≥ 18 years old.
  • DLMP employees who work on-site at SDSC.
  • Plan to complete the two dose SARS-CoV-2 vaccination schedule.

Exclusion Criteria:

  • Children < 18 years old.
  • Subjects who have previously been diagnosed with SARS-CoV-2 infection.
  • Subjects who test SARS-CoV-2 antibody positive on the pre-vaccination sample indicating prior infection.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Elitza Theel, Ph.D.

Closed-enrolling by invitation

What is this? (?)
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Katelyn Reed B.S., M.H.S.

(507) 284-0503


More information


Publications are currently not available

Mayo Clinic Footer